Bart A. Westerman

6.9k total citations
52 papers, 1.3k citations indexed

About

Bart A. Westerman is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Bart A. Westerman has authored 52 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 13 papers in Genetics and 8 papers in Oncology. Recurrent topics in Bart A. Westerman's work include Glioma Diagnosis and Treatment (12 papers), Epigenetics and DNA Methylation (9 papers) and Prenatal Screening and Diagnostics (6 papers). Bart A. Westerman is often cited by papers focused on Glioma Diagnosis and Treatment (12 papers), Epigenetics and DNA Methylation (9 papers) and Prenatal Screening and Diagnostics (6 papers). Bart A. Westerman collaborates with scholars based in Netherlands, United States and United Kingdom. Bart A. Westerman's co-authors include Cees B.M. Oudejans, Georgi K. Kanev, Chris de Graaf, Albert J. Kooistra, Iwan J. P. de Esch, Inge J. van Wijk, Thomas Würdinger, Ankie Poutsma, J. M. G. van Vugt and Monique A. M. Mulders and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Bart A. Westerman

50 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bart A. Westerman Netherlands 21 769 225 182 181 174 52 1.3k
Alexander Thompson United Kingdom 25 1.3k 1.6× 196 0.9× 220 1.2× 106 0.6× 44 0.3× 68 1.9k
Peter Tsang Canada 17 835 1.1× 56 0.2× 178 1.0× 121 0.7× 192 1.1× 33 1.7k
Michael Zager United States 6 781 1.0× 159 0.7× 153 0.8× 92 0.5× 28 0.2× 12 1.0k
Dorina Gui United States 23 862 1.1× 345 1.5× 243 1.3× 191 1.1× 43 0.2× 52 1.7k
Andrew Chi United States 17 329 0.4× 174 0.8× 160 0.9× 210 1.2× 55 0.3× 34 871
Hisham Mohammed United Kingdom 17 1.3k 1.7× 246 1.1× 181 1.0× 32 0.2× 48 0.3× 29 1.7k
Yvon E. Cayre France 23 855 1.1× 533 2.4× 369 2.0× 110 0.6× 48 0.3× 38 2.0k
Agnes S. Lo United States 20 418 0.5× 505 2.2× 100 0.5× 55 0.3× 237 1.4× 28 1.4k
Dana A. M. Mustafa Netherlands 20 589 0.8× 476 2.1× 339 1.9× 245 1.4× 30 0.2× 84 1.4k
Maria P. Alcolea United Kingdom 16 639 0.8× 287 1.3× 222 1.2× 32 0.2× 39 0.2× 29 1.2k

Countries citing papers authored by Bart A. Westerman

Since Specialization
Citations

This map shows the geographic impact of Bart A. Westerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart A. Westerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart A. Westerman more than expected).

Fields of papers citing papers by Bart A. Westerman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bart A. Westerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart A. Westerman. The network helps show where Bart A. Westerman may publish in the future.

Co-authorship network of co-authors of Bart A. Westerman

This figure shows the co-authorship network connecting the top 25 collaborators of Bart A. Westerman. A scholar is included among the top collaborators of Bart A. Westerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bart A. Westerman. Bart A. Westerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yaqub, Maqsood, Victor L. Thijssen, Adrianus J. de Langen, et al.. (2025). Physiologically Based Pharmacokinetic Model of Tyrosine Kinase Inhibitors to Predict Target Site Penetration, with PET‐Guided Verification. CPT Pharmacometrics & Systems Pharmacology. 14(5). 918–928. 1 indexed citations
2.
Hijfte, Levi van, Marjolein Geurts, Iris de Heer, et al.. (2025). Gemistocytic tumor cells programmed for glial scarring characterize T cell confinement in IDH-mutant astrocytoma. Nature Communications. 16(1). 1156–1156. 2 indexed citations
3.
Narayan, Ravi S., Sander R. Piersma, Thang V. Pham, et al.. (2025). Combined Inactivation of MEK and mTOR Can Lead to Synergistic Cell Death in Glioblastoma Models and Associates with NF1 Deficiency and a Mesenchymal Subtype. Molecular Cancer Therapeutics. 24(12). 1878–1889.
4.
Cai, Xue, et al.. (2024). P02.05.A COMPREHENSIVE ANALYSIS OF TUMOR-ASSOCIATED MACROPHAGES IN GLIOBLASTOMA. Neuro-Oncology. 26(Supplement_5). v35–v35. 1 indexed citations
5.
Küçükosmanoğlu, Aslι, Nicoleta Sp̂înu, Georgi K. Kanev, et al.. (2024). A Real-world Toxicity Atlas Shows that Adverse Events of Combination Therapies Commonly Result in Additive Interactions. Clinical Cancer Research. 30(8). 1685–1695. 5 indexed citations
6.
Giczewska, Anna, Laurine E. Wedekind, David P. Noske, et al.. (2023). Longitudinal drug synergy assessment using convolutional neural network image-decoding of glioblastoma single-spheroid cultures. Neuro-Oncology Advances. 5(1). vdad134–vdad134. 1 indexed citations
7.
Giczewska, Anna, Aslι Küçükosmanoğlu, Rogier C. Buijsman, et al.. (2023). Screening of predicted synergistic multi-target therapies in glioblastoma identifies new treatment strategies. Neuro-Oncology Advances. 5(1). vdad073–vdad073. 8 indexed citations
8.
Lagerweij, Tonny, S. Heukelom, Phil W. Koken, et al.. (2022). Radio-sensitizing effect of MEK inhibition in glioblastoma in vitro and in vivo. Journal of Cancer Research and Clinical Oncology. 149(1). 297–305. 6 indexed citations
9.
Jacobs, Sarah, Pieter Wesseling, Bart de Keizer, et al.. (2021). CXCR4 expression in glioblastoma tissue and the potential for PET imaging and treatment with [68Ga]Ga-Pentixafor /[177Lu]Lu-Pentixather. European Journal of Nuclear Medicine and Molecular Imaging. 49(2). 481–491. 26 indexed citations
10.
Hassouni, Btissame El, Giulia Mantini, Giovanna Li Petri, et al.. (2019). To Combine or Not Combine: Drug Interactions and Tools for Their Analysis. Reflections from the EORTC-PAMM Course on Preclinical and Early-phase Clinical Pharmacology. Anticancer Research. 39(7). 3303–3309. 26 indexed citations
11.
Kanev, Georgi K., Chris de Graaf, Iwan J. P. de Esch, et al.. (2019). The Landscape of Atypical and Eukaryotic Protein Kinases. Trends in Pharmacological Sciences. 40(11). 818–832. 95 indexed citations
12.
Narayan, Ravi S., Tonny Lagerweij, Jaap van den Berg, et al.. (2017). Identification of MEK162 as a Radiosensitizer for the Treatment of Glioblastoma. Molecular Cancer Therapeutics. 17(2). 347–354. 19 indexed citations
13.
Koppens, Martijn, Ellen Tanger, Karim Nacerddine, et al.. (2016). A new transgenic mouse model for conditional overexpression of the Polycomb Group protein EZH2. Transgenic Research. 26(2). 187–196. 7 indexed citations
14.
Huang, Sidong, Jamila Laoukili, Mirjam T. Epping, et al.. (2009). ZNF423 Is Critically Required for Retinoic Acid-Induced Differentiation and Is a Marker of Neuroblastoma Outcome. Cancer Cell. 15(4). 328–340. 112 indexed citations
15.
Westerman, Bart A., Ankie Poutsma, Eric A.P. Steegers, & Cees B.M. Oudejans. (2004). C2360, a nuclear protein expressed in human proliferative cytotrophoblasts, is a representative member of a novel protein family with a conserved coiled coil–helix–coiled coil–helix domain. Genomics. 83(6). 1094–1104. 20 indexed citations
16.
Westerman, Bart A., et al.. (2003). NEUROD1 acts in vitro as an upstream regulator of NEUROD2 in trophoblast cells. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1676(1). 96–103. 5 indexed citations
17.
Oudejans, Cees B.M., May Lee Tjoa, Bart A. Westerman, et al.. (2003). Circulating trophoblast in maternal blood. Prenatal Diagnosis. 23(2). 111–116. 47 indexed citations
18.
Westerman, Bart A., Ankie Poutsma, Renske D.M. Steenbergen, et al.. (2002). Quantitative reverse transcription-polymerase chain reaction measurement of HASH1 (ASCL1), a marker for small cell lung carcinomas with neuroendocrine features.. PubMed. 8(4). 1082–6. 41 indexed citations
19.
Westerman, Bart A., et al.. (2002). The proneural genes NEUROD1 and NEUROD2 are expressed during human trophoblast invasion. Mechanisms of Development. 113(1). 85–90. 19 indexed citations
20.
Oudejans, Cees B.M., Bart A. Westerman, Andrea A.M. Könst, et al.. (1997). Growth regulation of extraembryonic tissues. European Journal of Obstetrics & Gynecology and Reproductive Biology. 75(1). 29–32. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexander Thompson Breakdown of academic impact, for papers by Peter Tsang Breakdown of academic impact, for papers by Michael Zager Breakdown of academic impact, for papers by Dorina Gui Breakdown of academic impact, for papers by Andrew Chi Breakdown of academic impact, for papers by Hisham Mohammed Breakdown of academic impact, for papers by Yvon E. Cayre Breakdown of academic impact, for papers by Agnes S. Lo Breakdown of academic impact, for papers by Dana A. M. Mustafa Breakdown of academic impact, for papers by Maria P. Alcolea
Rankless by CCL
2026